drug-development – Page 8

Huntington's disease clinical trial announcement: huntingtin-lowering drug to enter Phase I trial in 2015

A clinical trial for an exciting therapy against HD is planned for 2015. The first step is to make sure it is safe.

November 4, 2014

The largest ever HD drug trial, testing coenzyme Q10, is halted for 'futility'. What does that mean for HD research?

August 13, 2014

Does a specific amino acid deficiency contribute to the development of HD?

April 21, 2014

Raptor Pharmaceuticals announces intermediate results from a long-term study of cysteamine in Huntington's disease

April 10, 2014

HDBuzz reports from the opening day of science sessions at the 2014 HD Therapeutics Conference in Palm Springs.

February 26, 2014

Results are in for a clinical trial testing the drug PBT2 for HD. Are the claims in the announcement justified?

February 20, 2014

A new study claims that high-dose creatine "slows the onset of Huntington Disease". How much hope and how much hype?

February 11, 2014

Roche's 'brain shuttle' sneaks drugs past the blood-brain barrier. Could it work for HD gene silencing drugs?

January 20, 2014

A recent HD animal study reveals that a small molecule drug could be an effective “Trk” to target for HD therapeutics

January 2, 2014

Why do certain brain cells die in HD? New research suggests is may be due to the efficiency of cellular recycling

November 12, 2013